Viral Interference During Influenza A–SARS-CoV-2 Coinfection of the Human Airway Epithelium and Reversal by Oseltamivir
Cheemarla N, Watkins T, Mihaylova V, Foxman E. Viral Interference During Influenza A–SARS-CoV-2 Coinfection of the Human Airway Epithelium and Reversal by Oseltamivir. The Journal Of Infectious Diseases 2023, 229: 1430-1434. PMID: 37722683, PMCID: PMC11095529, DOI: 10.1093/infdis/jiad402.Peer-Reviewed Original ResearchSARS-CoV-2 replicationSARS-CoV-2IAV replicationHuman airway epithelial culturesHuman airway epitheliumAirway epithelial culturesHost antiviral responseRobust interferon responseInfluenza infectionRespiratory virusesAirway epitheliumViral infectionAntiviral responseViral interferenceCoinfecting virusSimultaneous infectionHost cell defenseInterferon responseCoinfectionInfectionEpithelial culturesOseltamivirInfluenzaVirusCell defenseRespiratory viruses: New frontiers—a Keystone Symposia report
Cable J, Sun J, Cheon I, Vaughan A, Castro I, Stein S, López C, Gostic K, Openshaw P, Ellebedy A, Wack A, Hutchinson E, Thomas M, Langlois R, Lingwood D, Baker S, Folkins M, Foxman E, Ward A, Schwemmle M, Russell A, Chiu C, Ganti K, Subbarao K, Sheahan T, Penaloza‐MacMaster P, Eddens T. Respiratory viruses: New frontiers—a Keystone Symposia report. Annals Of The New York Academy Of Sciences 2023, 1522: 60-73. PMID: 36722473, PMCID: PMC10580159, DOI: 10.1111/nyas.14958.Peer-Reviewed Original ResearchConceptsRespiratory virusesSARS-CoV-2Specific viral strainsMechanisms of diseaseAcute infectionChronic diseasesCommon causeEffective treatmentNovel treatmentsVirus-host interactionsPrevention strategiesTherapy efficacyViral strainsVulnerable populationsPrevention approachesVirusDiseaseSymposium reportTreatmentViral biologyMorbidityPopulationInfectionMortalityInfluenza